Press releases
- Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results
- Harbour BioMed Announces Resubmission of Biologics License Application for Batoclimab to NMPA for Treatment of Generalized Myasthenia Gravis
- Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
Key statistics
As of last trade, Hbm Holdings Ltd (6XY:FRA) traded at 0.139, 43.30% above the 52 week low of 0.097 set on Apr 18, 2024.
52-week range
Open | 0.139 |
---|---|
High | 0.139 |
Low | 0.138 |
Bid | 0.150 |
Offer | 0.17 |
Previous close | 0.139 |
Average volume | 250.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 18 2024 14:29 BST.
More ▼